JP2022542918A5 - - Google Patents
Info
- Publication number
- JP2022542918A5 JP2022542918A5 JP2022505329A JP2022505329A JP2022542918A5 JP 2022542918 A5 JP2022542918 A5 JP 2022542918A5 JP 2022505329 A JP2022505329 A JP 2022505329A JP 2022505329 A JP2022505329 A JP 2022505329A JP 2022542918 A5 JP2022542918 A5 JP 2022542918A5
- Authority
- JP
- Japan
- Prior art keywords
- degrees
- compound
- value
- compound according
- peaks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1910664.0A GB201910664D0 (en) | 2019-07-25 | 2019-07-25 | Novel forms of compound |
| GB1910664.0 | 2019-07-25 | ||
| PCT/GB2020/051779 WO2021014167A1 (en) | 2019-07-25 | 2020-07-24 | Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542918A JP2022542918A (ja) | 2022-10-07 |
| JP2022542918A5 true JP2022542918A5 (https=) | 2023-07-28 |
| JP7627683B2 JP7627683B2 (ja) | 2025-02-06 |
Family
ID=67990591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022505329A Active JP7627683B2 (ja) | 2019-07-25 | 2020-07-24 | Ｎ－Ｔｅｒｔ－ブチル－４［［２－（５－クロロ－２－ヒドロキシ－フェニル）アセチル］アミノ］ピリジン－２－カルボキサミドの固体形態 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US12281077B2 (https=) |
| EP (1) | EP4003960A1 (https=) |
| JP (1) | JP7627683B2 (https=) |
| CN (1) | CN114585607B (https=) |
| AU (1) | AU2020318943A1 (https=) |
| BR (1) | BR112022001276A2 (https=) |
| CA (1) | CA3145285A1 (https=) |
| CL (1) | CL2022000187A1 (https=) |
| CO (1) | CO2022002046A2 (https=) |
| CR (2) | CR20220079A (https=) |
| GB (1) | GB201910664D0 (https=) |
| IL (1) | IL290071B1 (https=) |
| MX (1) | MX2022000891A (https=) |
| MY (1) | MY207877A (https=) |
| PE (1) | PE20221407A1 (https=) |
| PH (1) | PH12022550193A1 (https=) |
| UA (1) | UA129300C2 (https=) |
| WO (1) | WO2021014167A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005042524A1 (en) * | 2003-10-30 | 2005-05-12 | Virochem Pharma Inc. | Pyridine carboxamide and methods for inhibiting hiv integrase |
| CA2658362A1 (en) | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| WO2016042114A1 (en) * | 2014-09-19 | 2016-03-24 | F. Hoffmann-La Roche Ag | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis |
| WO2018195127A1 (en) | 2017-04-17 | 2018-10-25 | The Regents Of The University Of California | Substituted 2-acylamino-cycloakylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a |
| GB201801355D0 (en) | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
-
2019
- 2019-07-25 GB GBGB1910664.0A patent/GB201910664D0/en not_active Ceased
-
2020
- 2020-07-24 EP EP20751235.1A patent/EP4003960A1/en active Pending
- 2020-07-24 MX MX2022000891A patent/MX2022000891A/es unknown
- 2020-07-24 UA UAA202200857A patent/UA129300C2/uk unknown
- 2020-07-24 JP JP2022505329A patent/JP7627683B2/ja active Active
- 2020-07-24 MY MYPI2022000419A patent/MY207877A/en unknown
- 2020-07-24 IL IL290071A patent/IL290071B1/en unknown
- 2020-07-24 CR CR20220079A patent/CR20220079A/es unknown
- 2020-07-24 BR BR112022001276A patent/BR112022001276A2/pt unknown
- 2020-07-24 CA CA3145285A patent/CA3145285A1/en active Pending
- 2020-07-24 AU AU2020318943A patent/AU2020318943A1/en active Pending
- 2020-07-24 CR CR20250316A patent/CR20250316A/es unknown
- 2020-07-24 PE PE2022000136A patent/PE20221407A1/es unknown
- 2020-07-24 PH PH1/2022/550193A patent/PH12022550193A1/en unknown
- 2020-07-24 CN CN202080053826.8A patent/CN114585607B/zh active Active
- 2020-07-24 WO PCT/GB2020/051779 patent/WO2021014167A1/en not_active Ceased
-
2022
- 2022-01-24 CL CL2022000187A patent/CL2022000187A1/es unknown
- 2022-01-24 US US17/582,539 patent/US12281077B2/en active Active
- 2022-02-25 CO CONC2022/0002046A patent/CO2022002046A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022176979A5 (https=) | ||
| JP7675061B2 (ja) | ニコチンアミドリボフラノシド塩の製造方法、ニコチンアミドリボフラノシド塩自体、およびその使用 | |
| TW202002969A (zh) | 製備方法 | |
| SG174787A1 (en) | Process and intermediates for preparing integrase inhibitors | |
| JP2021501127A5 (https=) | ||
| IL315814A (en) | Crystalline forms of immunomodulators | |
| JP2024095561A5 (https=) | ||
| JP2022060192A5 (https=) | ||
| WO2011021218A2 (en) | Process for the preparation of 4-[3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl]-benzoic acid and its amine salts | |
| JP2021533116A (ja) | イサブコナゾニウム硫酸塩を精製するための方法 | |
| US12528771B2 (en) | Method for producing centanafadine | |
| HK1205505A1 (en) | A method of preparing a highly pure potassium salt of azilsartan medoxomil | |
| JP2022542918A5 (https=) | ||
| WO2015011659A1 (en) | Crystalline polymorphic forms of regorafenib and processes for the preparation of polymorph i of regorafenib | |
| JP2025041833A (ja) | 結晶形ｉｉのソタグリフロジンを調製する方法 | |
| WO2018185711A1 (en) | Solvates of eluxadoline | |
| EP3541788B1 (en) | Process for the purification of 1-(4-chlorophenyl)pyrazol-3-ol | |
| TW202012389A (zh) | 製備吡蟲啉（ｉｍｉｄａｃｌｏｐｒｉｄ）多晶型的方法 | |
| JP5952748B2 (ja) | フタロイルアムロジピンの新規結晶形態およびそれを用いる高純度なアムロジピンベシル酸塩の製造方法 | |
| JPH083170A (ja) | セファロスポリンの塩の精製 | |
| CN103739568B (zh) | 2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸a晶型的制备方法 | |
| WO2017167949A1 (en) | Crystalline forms of bilastine | |
| JP2023523165A5 (https=) | ||
| JP2012509305A (ja) | 結晶化ペンタサッカライド、これを得る方法、およびイドラパリナックスの調製のためのこの使用 | |
| RU2022104700A (ru) | Твердые формы n-трет-бутил-4[[2-(5-хлор-2-гидроксифенил)ацетил]амино]пиридин-2-карбоксамида |